leisure time -WSS

leisure time

author：knowledge 2025-08-19 18:07:04 - browse：1515

A syringe injects into a segment of DNA — biotech coverage from STAT — Adobe

Two congenitally deaf children can hear for the first time after being treated with gene therapy, according to data presented at a conference Wednesday.

The results are “jaw-droppingly good, just shocking how good. It exceeded the wildest expectations of anybody who started this work,” said Larry Lustig, an otolaryngologist at Columbia University and an investigator on the study.

The new data come from a larger study by Regeneron Pharmaceuticals that will treat nearly two dozen children with a specific type of congenital hearing loss with gene therapy. The clinical trial is meant to measure safety and efficacy of DB-OTO, a gene therapy drug Regeneron is developing to treat children who have hearing loss due to changes in the otoferlin gene. Several teams are targeting this rare form of congenital deafness that affects 1% to 8% of deaf people globally, including a team with Akouos, an Eli Lilly subsidiary, which successfully treated an 11-year-old boy with a similar gene therapy. Lustig calls this the “lowest of the low-hanging fruit” for gene therapy deafness treatments.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： New company forms to vet health AI models, root out weaknesses

WSS

Eat, drink, but be wary — 4 foods that interact with medications

Dems pitch expanding Medicare power to negotiate drug prices

Pediatricians' group reaffirms support for gender

Russian fighter jet damages US Reaper drone with flare over Syria: Officials

Prosecutors seek bail revocation for FTX founder Sam Bankman

CDC Director Mandy Cohen on transparency, trust, and health

focus

leisure time

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

knowledge

Dobbs anniversary: the lost opportunity of abortion as health care

Rise in cancer among younger people worries and puzzles doctors

Medicare details structure of new drug price negotiation program

The haunting brain science of long Covid

Psychedelics group wrestles with new pharma identity

Democrats decry new health bill for going easy on private equity

DIEP, the 'gold standard' of breast reconstruction, is under threat

Parkland mass shooting to be reenacted for lawsuit

Anesthesiologist group: stop taking Ozempic before surgery

In the gardens at Boston Children's Hospital, families find sanctuary

entertainment

US economic growth accelerated in 2nd quarter, exceeding expectations and quieting recession fears

Search called off for baby washed away in Pennsylvania flash flood

Rise in cancer among younger people worries and puzzles doctors

Former reverend arrested for allegedly killing 8

Rivals hope for voter 'fatigue' as Trump's woes mount but base stays loyal: ANALYSIS

Pediatricians' group reaffirms support for gender

leisure time

Wikipedia

Wikipedia

hotspot